Skip Navigation

European Heart Journal 2001 22(24):2219-2220; doi:10.1053/euhj.2001.2812
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lamblin, N.
Right arrow Articles by Helbecque, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamblin, N.
Right arrow Articles by Helbecque, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Gene polymorphisms of pro- (or anti-) inflammatory cytokines and vascular disease

N. Lamblina, C. Bautersa and N. Helbecqueb

a Cardiologie C, CHRU de Lille et INSERM U508, Lille, France
b INSERM U508, Lille, France

References

  1. Humphries SE, Luong LA, Ogg MA, Hawe E, Miller GJ. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J. 2001;22:2243–2252[Abstract/Free Full Text]
  2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–126[Free Full Text]
  3. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621–636[ISI][Medline]
  4. Seino Y, Ikeda U, Ikeda M. Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine. 1994;6:87–91[CrossRef][ISI][Medline]
  5. Biasucci LM, Bitelli A, Liuzzo G. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874–877[Abstract/Free Full Text]
  6. Ridker PM, Rifai N, Stampfer RJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767–1772[Abstract/Free Full Text]
  7. Libby P, Ridker PM. Novel inflammatory markers of coronary risk. Theory versus practice. Circulation. 1999;100:1148–1150[Free Full Text]
  8. Mallat Z, Heymes C, Ohan J, Faggin E, Leseche G, Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques. Relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol. 1999;19:611–616[Abstract/Free Full Text]
  9. Francis SE, Camp NJ, Dewberry RM. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation. 1999;99:861–866[Abstract/Free Full Text]
  10. Kastrati A, Koch W, Berger PB. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol. 2000;36:2168–2173[Abstract/Free Full Text]
  11. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effect of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94:3195–3199[Abstract/Free Full Text]
  12. Crawley E, Kay R, Sillibourne J, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 1999;42:1101–1108[CrossRef][ISI][Medline]
  13. Turner D, Grant SC, Yonan N. Cytokine gene polymorphism and heart transplant rejection. Transplantation. 1997;64:776–779[CrossRef][ISI][Medline]
  14. Lamblin N, Bauters C, Helbecque N, Hermant X, Bertrand ME, Amouyel P. MMP3 (stromelysin-1) genetic polymorphism distribution in patients with aneurysmal coronary artery disease (Abstr). J Am Coll Cardiol. 2001;37:252A
  15. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J. 1995;73:209–215[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lamblin, N.
Right arrow Articles by Helbecque, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamblin, N.
Right arrow Articles by Helbecque, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?